British Medical Bulletin 56:1054-1070 (2000)
© 2000 The British Council
research-article |
Heterogeneity of therapeutic responses in asthma
1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston USA
2Department of Respiratory Medicine and Allergy, Guy's, King's and Thomas School of Medicine, Guy's Hospital London, UK
Correspondence to:Prof. TH Lee, Department of Respiratory Medicine and Allergy, 5th floor Thomas Guy House, Guy's Hospital, London SEl 9RT, UK.
Abstract
Asthma is a complex clinical syndrome with multiple genetic and enviromental factors contributing to its phenotypic expression. This aetiological heterogeneity adds to the complexity when addressing variation in the response to antiasthma treatment. Currently, there are three main lines of treatment available: (i)inhaled glucocorticoids which have multiple mechanisms of action; (ii)ß2-agonists which are very effective bronchodilators and act predominantly on airway smooth muscle; and (iii) cysteinyl-leukotriene inhibitors. Analysis of the repeatability (r) of the treatment response, defined as the fraction of the total population variance which results from among-individual differences, shows values of r between 6080% indicating that a substantial fraction of the variance of the treatment respone could be genetic in nature. Among the sources of variability that could contribute to the observed heterogeneity in the response to treatment are the degree of underlying inflammation, such as in glucocorticoid resistance, and polymorphisms in the genes encoding the durg target, such as ß2-adrenoceptor and 5-lipoxygenase.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. C. Allen Searching for an improved mouse model of allergic airway disease using dual allergen exposures Dis. Model. Mech., November 1, 2009; 2(11-12): 519 - 520. [Full Text] [PDF] |
||||
![]() |
J. Rohan, D. Drotar, K. McNally, M. Schluchter, K. Riekert, P. Vavrek, A. Schmidt, S. Redline, and C. Kercsmar Adherence to Pediatric Asthma Treatment in Economically Disadvantaged African-American Children and Adolescents: An Application of Growth Curve Analysis J. Pediatr. Psychol., August 26, 2009; (2009) jsp074v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Goleva, L.-b. Li, and D. Y. M. Leung IFN-{gamma} Reverses IL-2- and IL-4-Mediated T-Cell Steroid Resistance Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Litonjua, J. Lasky-Su, K. Schneiter, K. G. Tantisira, R. Lazarus, B. Klanderman, J. J. Lima, C. G. Irvin, S. P. Peters, J. P. Hanrahan, et al. ARG1 Is a Novel Bronchodilator Response Gene: Screening and Replication in Four Asthma Cohorts Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panebra, M. R. Schwarb, C. B. Glinka, and S. B. Liggett Allele-Specific Binding of Airway Nuclear Extracts to Polymorphic beta2-Adrenergic Receptor 5' Sequence Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 654 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
S B Liggett Genetic variability of the {beta}2 adrenergic receptor and asthma exacerbations. Thorax, November 1, 2006; 61(11): 925 - 927. [Full Text] [PDF] |
||||
![]() |
M. Peters-Golden, A. Swern, S. S. Bird, C. M. Hustad, E. Grant, and J. M. Edelman Influence of body mass index on the response to asthma controller agents. Eur. Respir. J., March 1, 2006; 27(3): 495 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lima, S. Zhang, A. Grant, L. Shao, K. G. Tantisira, H. Allayee, J. Wang, J. Sylvester, J. Holbrook, R. Wise, et al. Influence of Leukotriene Pathway Polymorphisms on Response to Montelukast in Asthma Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 379 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wechsler and E. Israel How Pharmacogenomics Will Play a Role in the Management of Asthma Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 12 - 18. [Full Text] [PDF] |
||||
![]() |
K. G. Tantisira, K. M. Small, A. A. Litonjua, S. T. Weiss, and S. B. Liggett Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between {beta}-agonist and corticosteroid pathways Hum. Mol. Genet., June 15, 2005; 14(12): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Tantisira, E. S. Hwang, B. A. Raby, E. S. Silverman, S. L. Lake, B. G. Richter, S. L. Peng, J. M. Drazen, L. H. Glimcher, and S. T. Weiss TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids PNAS, December 28, 2004; 101(52): 18099 - 18104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Weiss, S. L. Lake, E. S. Silverman, E. K. Silverman, B. Richter, J. M. Drazen, and K. G. Tantisira Asthma Steroid Pharmacogenetics: A Study Strategy to Identify Replicated Treatment Responses Proceedings of the ATS, December 1, 2004; 1(4): 364 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Tantisira, S. Lake, E. S. Silverman, L. J. Palmer, R. Lazarus, E. K. Silverman, S. B. Liggett, E. W. Gelfand, L. J. Rosenwasser, B. Richter, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids Hum. Mol. Genet., July 1, 2004; 13(13): 1353 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wohlsen, C. Martin, E. Vollmer, D. Branscheid, H. Magnussen, W-M. Becker, U. Lepp, and S. Uhlig The early allergic response in small airways of human precision-cut lung slices Eur. Respir. J., June 1, 2003; 21(6): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Serhan, S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R.-L. Moussignac Resolvins: A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals J. Exp. Med., October 21, 2002; 196(8): 1025 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Palmer, E. S. Silverman, S. T. Weiss, and J. M. Drazen Pharmacogenetics of Asthma Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 861 - 866. [Full Text] [PDF] |
||||









